Asterias Biotherapeutics, Inc. (AST) has 14 open-market insider trades by 9 insiders since 2015. The most active filer is Richard T. LeBuhn, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Don M. Bailey | Dir | — | 1 | $598K | 2016-05-13 |
| Pedro Lichtinger | CEO | — | 1 | $500K | 2015-02-09 |
| Stephen LaHue Cartt | CEOPres | — | 2 | $171K | 2017-03-30 |
| Richard T. LeBuhn | Dir | — | 3 | $85K | 2016-06-29 |
| Natale S. Ricciardi | Dir | — | 2 | $72K | 2016-05-13 |
| Alfred D. Kingsley | Dir | — | 2 | $33K | 2016-06-09 |
| Andrew Arno | Dir | — | 1 | $22K | 2015-06-25 |
| Katharine E. Spink | EVP & COO | — | 1 | $20K | 2017-06-05 |
| Edward Wirth | Chief Medical Officer | — | 1 | $14K | 2019-03-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael H. Mulroy | President | Buy | $5K | 2018-08-27 |
| Michael H. Mulroy | President | Buy | $5K | 2018-07-25 |
| Michael H. Mulroy | President | Buy | $5K | 2018-06-25 |
| Michael H. Mulroy | President | Buy | $5K | 2018-05-25 |
| Michael H. Mulroy | President | Buy | $5K | 2018-04-25 |
| Michael H. Mulroy | President | Buy | $5K | 2018-03-26 |
Companies that share insiders with AST, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Michael H. Mulroy | President | Buy | $5K | 2018-02-26 |
| Michael H. Mulroy | President | Buy | $5K | 2018-01-25 |
| Michael H. Mulroy | President | Buy | $5K | 2017-12-26 |
| Michael H. Mulroy | President | Buy | $5K | 2017-11-27 |
| Michael H. Mulroy | President | Buy | $5K | 2017-10-25 |
| Michael H. Mulroy | President | Buy | $5K | 2017-09-25 |
| Edward Wirth | Chief Medical Officer | Sell | $16K | 2017-01-09 |
| Katharine E. Spink | COO | Sell | $22K | 2017-01-09 |
| Katharine E. Spink | COO | Sell | $13K | 2016-12-27 |